Article
Genetic Determinants of Hematopoietic Toxicity Risk in Thai Pediatric Patients Undergoing 6-Mercaptopurine Treatment.
Clinical and translational science - 1 Feb 2026
Khaeso Kanyarat, Chainansamit Su-On, Kuwatjanakul Pitchayanan, Komvilaisak Patcharee, Nakkam Nontaya, Suwannaying Kunanya, Vannaprasaht Suda, Dornsena Areerat, Tassaneeyakul Wichittra
Abstract excerpt
The nucleoside diphosphate-linked moiety X-type motif 15 (NUDT15) has been identified as a key genetic determinant of 6-mercaptopurine (6-MP)-induced hematopoietic toxicity in populations with a high frequency of NUDT15 variants but a low frequency of thiopurine S-methyltransferase (TPMT) variants. However, evidence remains limited in populations where both genetic variants are prevalent. This study aimed to...
Topics
Join the communities discussing this publication.
